(Q51385671)

4 April 2018

title

Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes. (English)

1 reference

4 April 2018

1 reference

5

R M Bergenstal

1 reference

4 April 2018

author name string

DREAM On (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication Ongoing Follow-up) Investigators

1

1 reference

4 April 2018

H C Gerstein

2

1 reference

4 April 2018

V Mohan

3

1 reference

4 April 2018

A Avezum

4

1 reference

4 April 2018

J-L Chiasson

6

1 reference

4 April 2018

M Garrido

7

1 reference

4 April 2018

I MacKinnon

8

1 reference

4 April 2018

P V Rao

9

1 reference

4 April 2018

B Zinman

10

1 reference

4 April 2018

H Jung

11

1 reference

4 April 2018

L Joldersma

12

1 reference

4 April 2018

J Bosch

13

1 reference

4 April 2018

S Yusuf

14

1 reference

4 April 2018

publication date

30 November 2010

1 reference

4 April 2018

published in

Diabetologia

1 reference

4 April 2018

volume

54

1 reference

4 April 2018

issue

3

1 reference

4 April 2018

page(s)

487-495

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s00125-010-1985-4

exact match

0 references

cites work

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Effect of ramipril on the incidence of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1985-4

10.1007/S00125-010-1985-4

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018